Clinical trial
Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients…
NCT00006799 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00006799 |
|---|---|
| Title | Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer |
| Official title | A Phase III, Double-Blind, Randomized Study Of The Effect Of Megestrol Acetate On Weight And Health Related Quality Of Life In Head And Neck Cancer Patients Receiving Radiation Therapy |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anorexia, Cachexia, Head and Neck Cancer, Quality of Life |
| Intervention type | Drug, Procedure |
| Interventions | megestrol acetate, quality-of-life assessment |
| Enrollment | 13 |
| Start date | Oct 1, 2000 |
| Primary completion | Sep 6, 2002 |
| Completion | Sep 6, 2002 |
| First posted | Jul 28, 2003 |
| Last update posted | Sep 9, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: